BCM
VATE icon

Bayesian Capital Management’s INNOVATE Corp VATE Stock Holding History

Bayesian Capital Management’s Portfolio VATE Stock Details VATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,231
Closed -$32K – 767
2018
Q4 		$32K Buy
+1,231
New +$51.9K 0.01% 585

Other funds holding VATE

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
MIM
Mittleman Investment Management Melville, New York $17.4M AUM 36.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bayesian Capital Management's VATE Position: Q1 2019 in Review

Bayesian Capital Management sold out of INNOVATE Corp (VATE) in Q1 2019, closing a stake of 1,231 shares — an estimated $32K sold.

Bayesian Capital Management first reported a position in VATE in Q4 2018 and held it in 1 quarter. The position peaked at $32K in Q4 2018. 92 funds tracked by Wall St. Rank hold VATE as of Q1 2019.

  • Bayesian Capital Management reported no remaining INNOVATE Corp position as of Q1 2019 after selling out during the quarter.
  • Bayesian Capital Management sold 1,231 INNOVATE Corp shares in Q1 2019, an estimated $32K.
  • Bayesian Capital Management first reported a position in INNOVATE Corp in Q4 2018 and held it in 1 quarter.
  • Bayesian Capital Management's INNOVATE Corp position peaked at $32K in Q4 2018.
  • 92 funds tracked by Wall St. Rank held INNOVATE Corp as of Q1 2019.

Based on Bayesian Capital Management's 13F filing for Q1 2019, filed 14 May 2019.